Abstract
Chronic pain is a widespread and debilitating condition that affects millions globally. The management of chronic pain remains a significant clinical challenge due to the limitations of current pharmacological treatments, which often present adverse effects and tolerance issues. Recent innovations in drug formulations have shown promise in improving pain management efficacy while reducing side effects. This article reviews the latest advancements in chronic pain drug formulations, including controlled-release systems, nanomedicine, and targeted drug delivery techniques. Emphasis is placed on how these innovations can optimize pain relief and enhance patient compliance.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.